Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Rucker

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Journal of Mental Health (Abingdon, England)|March 13, 2023
Psilocybin therapy for depression. A good trip?James J Rucker
Bjpsych Bulletin|May 29, 2023
Evidence versus expectancy: the development of psilocybin therapyJames J Rucker
Journal of Psychopharmacology (Oxford, England)|April 15, 2021
Psychedelics: Old drugs, new tripsJames J Rucker, Pallab Seth
Bjpsych Bulletin|June 26, 2023
The development of psilocybin therapy for treatment-resistant depression: an updateAnya Borissova, James J Rucker
Journal of Psychopharmacology (Oxford, England)|May 31, 2022
Postpartum depression: A role for psychedelics?Chaitra Jairaj, James J Rucker
Frontiers in Psychiatry|May 10, 2021
Psilocybin: From Serendipity to Credibility?James J Rucker, Allan H Young
Neuropsychiatric Disease and Treatment|October 11, 2023
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc AnalysisKwonmok Ko, Ben Carter, Anthony J Cleare, et al.
Frontiers in Psychiatry|August 4, 2022
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic ReviewKwonmok Ko, Gemma Knight, James J Rucker, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2024
Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)Emma I Kopra, Jenni Penttinen, James J Rucker, et al.
Journal of Affective Disorders|October 9, 2022
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysisKwonmok Ko, Emma I Kopra, Anthony J Cleare, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Journal of Mental Health (Abingdon, England)|March 13, 2023
Psilocybin therapy for depression. A good trip?James J Rucker
Bjpsych Bulletin|May 29, 2023
Evidence versus expectancy: the development of psilocybin therapyJames J Rucker
Journal of Psychopharmacology (Oxford, England)|April 15, 2021
Psychedelics: Old drugs, new tripsJames J Rucker, Pallab Seth
Bjpsych Bulletin|June 26, 2023
The development of psilocybin therapy for treatment-resistant depression: an updateAnya Borissova, James J Rucker
Journal of Psychopharmacology (Oxford, England)|May 31, 2022
Postpartum depression: A role for psychedelics?Chaitra Jairaj, James J Rucker
Frontiers in Psychiatry|May 10, 2021
Psilocybin: From Serendipity to Credibility?James J Rucker, Allan H Young
Neuropsychiatric Disease and Treatment|October 11, 2023
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc AnalysisKwonmok Ko, Ben Carter, Anthony J Cleare, et al.
Frontiers in Psychiatry|August 4, 2022
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic ReviewKwonmok Ko, Gemma Knight, James J Rucker, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2024
Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)Emma I Kopra, Jenni Penttinen, James J Rucker, et al.
Journal of Affective Disorders|October 9, 2022
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysisKwonmok Ko, Emma I Kopra, Anthony J Cleare, et al.
Pageof 7